MeSH tree: C08.381.483.652
Researchers at Texas Biomedical Research Institute have developed a new, proof-of-concept vaccine to protect people from the bird flu strain currently circulating in the United States. The team, led by Professor Luis Martinez-Sobrido, ...
Aug 20, 2025
0
58
Researchers have found a promising treatment breakthrough for chronic obstructive pulmonary disease (COPD) that avoids many of the drawbacks of current drugs, and it has come from an unexpected place.
Aug 12, 2025
0
62
Visible on chest CT scans, post-COVID-19 residual lung abnormalities, which affect up to 50% of patients who have had an infection requiring hospitalization, may be associated with persistent or progressive respiratory symptoms ...
Jul 22, 2025
0
21
UBC Okanagan researchers have developed a 3D bio-printed model that closely mimics the complexity of natural lung tissue, an innovation that could transform how scientists study lung disease and develop new treatments.
Jul 15, 2025
0
24
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have identified a previously overlooked protein, Epac1, as a key driver of idiopathic pulmonary fibrosis (IPF), a chronic and progressive lung-scarring ...
Jul 15, 2025
0
18
Lung macrophages play a pivotal role in diseases like idiopathic pulmonary fibrosis. Two types of macrophages—the white blood cells that defend the body by killing microbes, removing dead cells and stimulating immune responses—are ...
Jul 3, 2025
0
97
The secrets of idiopathic pulmonary fibrosis (IPF) are written in its very name. Idiopathic refers to a disease of unknown cause, and the condition, which turns healthy lung tissue into fibrous scar tissue, still raises many ...
Jun 23, 2025
0
21
Women age differently from men when it comes to health—particularly in conditions like cardiovascular disease and neurodegenerative disorders such as dementia and Parkinson's.
May 27, 2025
0
57
For gene therapy to work well, therapeutic molecules need to be efficiently delivered to the correct locations in the body—a job commonly given to adeno-associated viruses (AAV).
May 22, 2025
0
27
A new drug for pulmonary fibrosis has reduced disease progression by more than 50% over a 52-week treatment in two clinical trials. Pulmonary fibrosis is a very serious disease, with a life prognosis of 3 to 5 years after ...
May 21, 2025
0
49
